Vetoquinol (XPAR:VETO) ROCE %: 14.97% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:VETO Vetoquinol SA XPAR:VETO
94 GF Score
Price €71.70
GF Value €85.39
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Vetoquinol ROCE %?

Vetoquinol XPAR:VETO -1.78% 94 ROCE % is 14.97% as of Dec. 2025. GuruFocus rates XPAR:VETO with a GF Score™ of 94/100 and a GF Value™ of €85.39 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vetoquinol's annualized ROCE % for the quarter that ended in Dec. 2025 was 14.97%.

Vetoquinol  (XPAR:VETO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vetoquinol ROCE % Related Terms

Vetoquinol ROCE % Historical Data

* Premium members only.

The historical data trend for Vetoquinol's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vetoquinol ROCE % Chart

Vetoquinol Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.94 15.07 14.63 14.21 13.39

Vetoquinol Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.79 12.69 15.90 12.18 14.97
XPAR:VETO
94GF Score
Vetoquinol SA XPAR:VETO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vetoquinol ROCE % Calculation

Vetoquinol's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=81.53/( ( (744.133 - 141.531) + (763.632 - 148.673) )/ 2 )
=81.53/( (602.602+614.959)/ 2 )
=81.53/608.7805
=13.39 %

Vetoquinol's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=90.306/( ( (725.817 - 133.88) + (763.632 - 148.673) )/ 2 )
=90.306/( ( 591.937 + 614.959 )/ 2 )
=90.306/603.448
=14.97 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.97% mean?
Vetoquinol (XPAR:VETO) has a ROCE % of 14.97% as of Dec. 2025.
Is Vetoquinol's ROCE % too high?
Vetoquinol's current ROCE % is 14.97%. The Drug Manufacturers industry median ROCE % is 7.03. Vetoquinol's value of 14.97% is 112.9% above this industry median. Overall, Vetoquinol has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetoquinol's ROCE % compare to ZTS and UTHR?
Vetoquinol's ROCE % of 14.97% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Vetoquinol's value of 14.97% is 112.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vetoquinol's current ROCE % of 14.97% is 112.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vetoquinol's current ROCE % is 14.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetoquinol stock overvalued right now?
Based on GuruFocus' analysis, Vetoquinol (XPAR:VETO) is currently considered Modestly Undervalued. The stock's GF Value™ is €85.39, compared to a current price of €71.70 — trading 16% below its estimated fair value. The current ROCE % is 14.97% and 112.9% above the Drug Manufacturers industry median of 7.03. Vetoquinol's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vetoquinol (XPAR:VETO), the current ROCE % is 14.97% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vetoquinol (XPAR:VETO) Overvalued in 2026?

Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued. The current stock price of €71.70 is trading 16% below its estimated GF Value™ of €85.39. GuruFocus considers Vetoquinol to be Modestly Undervalued.

Key valuation signals for XPAR:VETO:

  • ROCE %: 14.97%
  • GF Value™: €85.39 vs. price of €71.70 (16% below fair value)
  • GF Score™: 94/100 with 1 warning sign
  • Industry Position: 112.9% above the Drug Manufacturers median

No single metric tells the full story. See the XPAR:VETO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vetoquinol Business Description

Other Exchanges 0O1O:UK8JM:Germany
Address Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
94GF Score

Get the complete analysis for XPAR:VETO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€71.70
Price
€85.39
GF Value